ChemoMetec A/S (CPH: CHEMM)
374.60
-5.60 (-1.47%)
Aug 30, 2024, 4:59 PM CET
ChemoMetec Revenue
ChemoMetec had revenue of 199.80M DKK in the half year ending December 31, 2023, a decrease of -4.77%. This brings the company's revenue in the last twelve months to 401.54M, down -12.94% year-over-year. In the fiscal year ending June 30, 2023, ChemoMetec had annual revenue of 444.40M with 3.74% growth.
Revenue (ttm)
401.54M
Revenue Growth
-12.94%
P/S Ratio
16.25
Revenue / Employee
2.35M
Employees
167
Market Cap
6.52B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Jun 30, 2023 | 444.40M | 16.01M | 3.74% |
Jun 30, 2022 | 428.39M | 147.26M | 52.38% |
Jun 30, 2021 | 281.13M | 67.03M | 31.31% |
Jun 30, 2020 | 214.10M | 38.59M | 21.99% |
Jun 30, 2019 | 175.51M | 62.83M | 55.75% |
Jun 30, 2018 | Pro | Pro | Pro |
Jun 30, 2017 | Pro | Pro | Pro |
Jun 30, 2016 | Pro | Pro | Pro |
Jun 30, 2015 | Pro | Pro | Pro |
Jun 30, 2014 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Novo Nordisk A/S | 258.00B |
Coloplast A/S | 26.30B |
Genmab A/S | 19.02B |
Demant A/S | 22.84B |
Zealand Pharma A/S | 367.97M |
H. Lundbeck A/S | 20.67B |
H. Lundbeck A/S | 20.67B |
ALK-Abelló A/S | 5.18B |